Fractional CO2 laser treatment
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Massachusetts General Hospital
Overview
Fractional CO2 laser treatment is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Fractional CO2 laser treatment clinical trials
Explore related
Medical disclaimer. This page summarizes research about Fractional CO2 laser treatment for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.